GLP-1 receptor agonists, including Ozempic, Wegovy, and Zepbound, have gained widespread attention as powerful tools for weight loss and appetite regulation
Berg JM, Geschwind DH
The researchers analyzed the medical records of over a half million people with a history of opioid use disorder (OUD) and over 800,000 people with a history of alcohol use disorder (AUD)
doi: 10.1016/0006-3223(89)90203-5 202 GermainLChouinardG
The Hepatocellular Carcinoma Database (HCCDB) includes ten standardized HCC subdatasets (OEP000321, GSE22058, GSE36376, GSE54236, GSE63898, GSE25097, GSE76427, GSE121248, GSE89377, and GSE87639), comprising a total of 1359 HCC samples and 974 adjacent nontumor samples and is also accessible online [27]